NDC 72834-210 Rabeprazole Sodium Delayed-release
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 72834 - Sarras Health, Llc
- 72834-210 - Rabeprazole Sodium Delayed-release
Product Characteristics
WHITE (C48325 - OPAQUE)
Product Packages
NDC Code 72834-210-30
Package Description: 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC
Product Details
What is NDC 72834-210?
What are the uses for Rabeprazole Sodium Delayed-release?
Which are Rabeprazole Sodium Delayed-release UNII Codes?
The UNII codes for the active ingredients in this product are:
- RABEPRAZOLE SODIUM (UNII: 3L36P16U4R)
- RABEPRAZOLE (UNII: 32828355LL) (Active Moiety)
Which are Rabeprazole Sodium Delayed-release Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- DIACETYLATED MONOGLYCERIDES (UNII: 5Z17386USF)
- ETHYLCELLULOSES (UNII: 7Z8S9VYZ4B)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) (UNII: 87Y6436BKR)
- MAGNESIUM OXIDE (UNII: 3A3U0GI71G)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MANNITOL (UNII: 3OWL53L36A)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- CARRAGEENAN (UNII: 5C69YCD2YJ)
- POTASSIUM CHLORIDE (UNII: 660YQ98I10)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for Rabeprazole Sodium Delayed-release?
- RxCUI: 1483318 - RABEprazole sodium 10 MG Delayed Release Oral Granules
- RxCUI: 1483318 - rabeprazole sodium 10 MG Oral Granules
- RxCUI: 1483318 - rabeprazole sodium 10 MG Delayed Release Oral Sprinkle Capsule
* Please review the disclaimer below.
Patient Education
Rabeprazole
Rabeprazole is used to treat the symptoms of gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube that connects the throat and stomach) in adults and children 12 year of age and older. Rabeprazole is used to treat damage from GERD, allow the esophagus to heal, and prevent further damage to the esophagus in adults. Rabeprazole is also used to treat conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome in adults. Rabeprazole is used to treat ulcers (sores in the lining of the stomach or intestine) and is used in combination with other medications to eliminate H. pylori (a bacteria that causes ulcers) in adults. Rabeprazole is in a class of medications called proton-pump inhibitors. It works by decreasing the amount of acid made in the stomach.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".